186 related articles for article (PubMed ID: 8765241)
1. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.
Hanigan MH; Gallagher BC; Taylor PT
Am J Obstet Gynecol; 1996 Aug; 175(2):270-3; discussion 273-4. PubMed ID: 8765241
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.
Townsend DM; Hanigan MH
J Pharmacol Exp Ther; 2002 Jan; 300(1):142-8. PubMed ID: 11752109
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
Hanigan MH; Gallagher BC; Taylor PT; Large MK
Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
[TBL] [Abstract][Full Text] [Related]
4. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin.
Hanigan MH; Lykissa ED; Townsend DM; Ou CN; Barrios R; Lieberman MW
Am J Pathol; 2001 Nov; 159(5):1889-94. PubMed ID: 11696449
[TBL] [Abstract][Full Text] [Related]
5. Acivicin-induced alterations in renal and hepatic glutathione concentrations and in gamma-glutamyltransferase activities.
Lantum HB; Iyer RA; Anders MW
Biochem Pharmacol; 2004 Apr; 67(7):1421-6. PubMed ID: 15013858
[TBL] [Abstract][Full Text] [Related]
6. Elimination of glutathione-induced protection from hyperbaric hyperoxia by acivicin.
Peacock MD; Schenk DA; Lawrence RA; Morgan JA; Jenkinson SG
J Appl Physiol (1985); 1994 Mar; 76(3):1279-84. PubMed ID: 7911799
[TBL] [Abstract][Full Text] [Related]
7. Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity II. Possible involvement of the gamma-glutamyl cycle.
Stern ST; Bruno MK; Horton RA; Hill DW; Roberts JC; Cohen SD
Toxicol Appl Pharmacol; 2005 Jan; 202(2):160-71. PubMed ID: 15629191
[TBL] [Abstract][Full Text] [Related]
8. Effects of AT-125 on the nephrotoxicity of hexachloro-1,3-butadiene in rats.
Davis ME
Toxicol Appl Pharmacol; 1988 Aug; 95(1):44-52. PubMed ID: 2901150
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase.
Hausheer FH; Shanmugarajah D; Leverett BD; Chen X; Huang Q; Kochat H; Petluru PN; Parker AR
Cancer Chemother Pharmacol; 2010 Apr; 65(5):941-51. PubMed ID: 19714332
[TBL] [Abstract][Full Text] [Related]
10. The gamma-glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture.
Dringen R; Kranich O; Hamprecht B
Neurochem Res; 1997 Jun; 22(6):727-33. PubMed ID: 9178957
[TBL] [Abstract][Full Text] [Related]
11. Organic anion transport and action of gamma-glutamyl transpeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury.
Zalups RK
Toxicol Appl Pharmacol; 1995 Jun; 132(2):289-98. PubMed ID: 7785056
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
14. Ergothioneine mitigates cisplatin-evoked nephrotoxicity via targeting Nrf2, NF-κB, and apoptotic signaling and inhibiting γ-glutamyl transpeptidase.
Salama SA; Abd-Allah GM; Mohamadin AM; Elshafey MM; Gad HS
Life Sci; 2021 Aug; 278():119572. PubMed ID: 33964294
[TBL] [Abstract][Full Text] [Related]
15. In vivo nephrotoxic action of an isomeric mixture of S-(1-phenyl-2-hydroxyethyl)glutathione and S-(2-phenyl-2-hydroxyethyl)glutathione in Fischer-344 rats.
Chakrabarti S; Malick MA
Toxicology; 1991 Mar; 67(1):15-27. PubMed ID: 1673268
[TBL] [Abstract][Full Text] [Related]
16. A study of the protective effect of chloride salts on cisplatin nephrotoxicity.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1985 Jul; 34(13):2363-9. PubMed ID: 4040367
[TBL] [Abstract][Full Text] [Related]
17. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Osman NM; Copley MP; Litterst CL
Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
[TBL] [Abstract][Full Text] [Related]
18. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Ueda T; Kumazawa J
Res Exp Med (Berl); 1996; 196(4):211-7. PubMed ID: 8903096
[TBL] [Abstract][Full Text] [Related]
19. Net efflux of cysteine, glutathione and related metabolites from rat hippocampal slices during oxygen/glucose deprivation: dependence on gamma-glutamyl transpeptidase.
Li X; Wallin C; Weber SG; Sandberg M
Brain Res; 1999 Jan; 815(1):81-8. PubMed ID: 9974125
[TBL] [Abstract][Full Text] [Related]
20. The in vivo disposition of 2-bromo-[14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition.
Lau SS; Monks TJ
Toxicol Appl Pharmacol; 1990 Mar; 103(1):121-32. PubMed ID: 1969181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
